Investigating histological aspects of scars in children.

OBJECTIVE Very little is known about histological aspects of paediatric scars and the possible role of the immune system during their formation. In this study, the histology thoracic scars caused by the placement of an implantable central venous access device in children who underwent treatment for cancer was assessed. METHOD The amount and type of collagen, the collagen orientation, the type of elastic fibres, the vascularsation, and the count of neutrophils, macrophages, and lymphocytes were analysed. The severity of scarring was assessed using the Vancouver scar scale (VSS). To evaluate the role of the immune system on scar severity and histology, the scars of children suffering from acute lymphoblastic leukaemia (ALL) were compared with the scars of children suffering from other types of childhood cancer. RESULTS Our results showed an extremely random orientation of the collagen fibres of the paediatric scars with a mean collagen orientation index of 0.22 (standard deviation (SD) 0.10, zero indicating a perfectly random orientation and a perfectly parallel orientation). A lower collagen orientation index was seen in scars with a lower VSS score (VSS score <3: 0.19 versus VSS score ≥3 0.29, p=0.037). A higher total VSS score, resembling a worse scar, was assessed to the scars in the non-ALL group compared with the children with ALL (mean ALL: 0.91 (0-3) versus mean non-ALL: 2.50 (0-6), p=0.037). CONCLUSION To our knowledge, this is the first study investigating a wide array of histological aspects in paediatric scars. Compared with adult scars, an extremely random collagen orientation was found (0.22 in children versus 0.41 and 0.46 adult normotrophic and hypertrophic scars, respectively). A lower collagen orientation index was found in scars with a lower VSS score. In addition, less severe scarring was measured in children suffering from ALL compared with children suffering from other types of childhood cancer. This suggests that the immune system could play a role in the development of aberrant scarring and should be a target for future research.

[1]  S. Gibbs,et al.  Suppressed inflammatory gene expression during human hypertrophic scar compared to normotrophic scar formation , 2015, Experimental dermatology.

[2]  P. Verhaegen,et al.  No Efficacy for Silicone Gel Sheeting in Prevention of Abnormal Scar Formation in Children with Cancer: A Randomized Controlled Trial , 2015, Plastic and reconstructive surgery.

[3]  K. Braam,et al.  Totally Implantable Venous Access Device in Children with Cancer Lead to Disfiguring scar , 2013, Pediatric hematology and oncology.

[4]  E. Middelkoop,et al.  Adaptation of the dermal collagen structure of human skin and scar tissue in response to stretch: An experimental study , 2012, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[5]  P. V. van Zuijlen,et al.  A Clinimetric Overview of Scar Assessment Scales , 2012, Journal of burn care & research : official publication of the American Burn Association.

[6]  S. Nagel,et al.  Satisfaction and quality of life: a survey-based assessment in patients with a totally implantable venous port system. , 2012, European journal of cancer care.

[7]  Grietje Molema,et al.  Time course of the angiogenic response during normotrophic and hypertrophic scar formation in humans , 2011, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[8]  H Peter Lorenz,et al.  Scarless fetal wound healing: a basic science review. , 2010, Plastic and reconstructive surgery.

[9]  Paul P M van Zuijlen,et al.  Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: An objective histopathological analysis , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[10]  H. Karanlık,et al.  Modification of approach for totally implantable venous access device decreases rate of complications , 2009, Journal of surgical oncology.

[11]  K. Braam,et al.  Psychosexual functioning of childhood cancer survivors , 2008, Psycho-oncology.

[12]  Dario Gregori,et al.  Epidemiology and risk factors for pathologic scarring after burn wounds. , 2008, Archives of facial plastic surgery.

[13]  G P Siegal,et al.  Immunohistochemistry in the evaluation of neovascularization in tumor xenografts , 2008, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[14]  I. Olivotto,et al.  Reliability and Validity Testing of the Patient and Observer Scar Assessment Scale in Evaluating Linear Scars after Breast Cancer Surgery , 2007, Plastic and reconstructive surgery.

[15]  U. Mrowietz,et al.  Quality of life of patients with keloid and hypertrophic scarring , 2006, Archives of Dermatological Research.

[16]  D. Sharpe,et al.  Quantifying Collagen Type in Mature Burn Scars: A Novel Approach Using Histology and Digital Image Analysis , 2006, Journal of burn care & research : official publication of the American Burn Association.

[17]  P. V. van Zuijlen,et al.  Reliable and Feasible Evaluation of Linear Scars by the Patient and Observer Scar Assessment Scale , 2005, Plastic and reconstructive surgery.

[18]  A. Desmoulière,et al.  Fibrillin‐1 and elastin are differentially expressed in hypertrophic scars and keloids , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[19]  F. Wood,et al.  [International clinical recommendations on scar management]. , 2002, Zentralblatt fur Chirurgie.

[20]  R. Kloner,et al.  Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light , 1994, Basic Research in Cardiology.

[21]  J. Bakkeren,et al.  Recovery of immune function after cessation of maintenance therapy in acute lymphoblastic leukemia (ALL) of childhood , 1982, European Journal of Pediatrics.

[22]  J. Peltonen,et al.  A fibroblast cell line cultured from a hypertrophic scar displays selective downregulation of collagen gene expression: barely detectable messenger RNA levels of the proα1(III) chain of type III collagen , 2004, Archives of Dermatological Research.

[23]  Ardeshir Bayat,et al.  Genetic Susceptibility to Keloid Disease and Hypertrophic Scarring: Transforming Growth Factor &bgr;1 Common Polymorphisms and Plasma Levels , 2003, Plastic and reconstructive surgery.

[24]  Luís Cristóvão Porto,et al.  Vascularization pattern in hypertrophic scars and keloids: a stereological analysis. , 2003, Pathology, research and practice.

[25]  Jan van Marle,et al.  Morphometry of dermal collagen orientation by Fourier analysis is superior to multi‐observer assessment , 2002, The Journal of pathology.

[26]  P. Engström,et al.  Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. , 2002, Pediatrics.

[27]  T. Abribat,et al.  DEVELOPMENT OF NONINVASIVE AND QUANTITATIVE METHODOLOGIES FOR THE ASSESSMENT OF CHRONIC ULCERS AND SCARS IN HUMANS , 2001, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[28]  J. Bos,et al.  Dermal Organization in Scleroderma: The Fast Fourier Transform and the Laser Scatter Method Objectify Fibrosis in Nonlesional as well as Lesional Skin , 2000, Laboratory Investigation.

[29]  M Kon,et al.  On the nature of hypertrophic scars and keloids: a review. , 1999, Plastic and reconstructive surgery.

[30]  H. Kock,et al.  Implantable Vascular Access Systems: Experience in 1500 Patients with Totally Implanted Central Venous Port Systems , 1998, World Journal of Surgery.

[31]  D. Arber,et al.  Paraffin section immunophenotyping of acute leukemias in bone marrow specimens. , 1996, American journal of clinical pathology.

[32]  M. Baryza,et al.  The Vancouver Scar Scale: an administration tool and its interrater reliability. , 1995, The Journal of burn care & rehabilitation.

[33]  S. Phan,et al.  Increased types I and III collagen and transforming growth factor-beta 1 mRNA and protein in hypertrophic burn scar. , 1995, The Journal of investigative dermatology.

[34]  D. W. Friedman,et al.  Regulation of collagen gene expression in keloids and hypertrophic scars. , 1993, The Journal of surgical research.

[35]  K. S. Lee,et al.  Collagen mRNA expression detected by in situ hybridization in keloid tissue. , 1991, Journal of dermatological science.

[36]  D R Boughner,et al.  Analysis of healing after myocardial infarction using polarized light microscopy. , 1989, The American journal of pathology.

[37]  M. Frohlich.  Birefringent objects visualized by circular polarization microscopy. , 1986, Stain technology.

[38]  Paul J. Kurtin,et al.  Leukocyte common antigen--a diagnostic discriminant between hematopoietic and nonhematopoietic neoplasms in paraffin sections using monoclonal antibodies: correlation with immunologic studies and ultrastructural localization. , 1985, Human pathology.

[39]  E. Deitch,et al.  Hypertrophic burn scars: analysis of variables. , 1983, The Journal of trauma.

[40]  R. Aur,et al.  Childhood acute lymphocytic leukemia. Study VIII , 1978, Cancer.

[41]  R. Brentani,et al.  Differential staining of collagens type I, II and III by Sirius Red and polarization microscopy. , 1978, Archivum histologicum Japonicum = Nihon soshikigaku kiroku.